Advertisement

HNO

, Volume 52, Issue 2, pp 112–120 | Cite as

Riechstörungen

Epidemiologie und Therapie in Deutschland, Österreich und der Schweiz
  • M. Damm
  • A. Temmel
  • A. Welge-Lüssen
  • H. E. Eckel
  • M.-P. Kreft
  • J. P. Klussmann
  • H. Gudziol
  • K.-B. Hüttenbrink
  • T. Hummel
Originalien

Zusammenfassung

Hintergrund

In den USA erkranken pro Jahr ca. 200.000 Patienten neu an Riechstörungen. Epidemiologische Daten liegen für den deutschsprachigen Raum nicht vor.

Ziel und Fragestellung

Erhebung von Prävalenzen, Ursachen und Therapiekonzepten von/bei Riechstörungen im deutschsprachigen Raum.

Methoden und Ergebnisse

Ein Fragebogen zu Riechstörungen und deren Therapie wurde an alle HNO-Kliniken in Deutschland, Österreich und der Schweiz verschickt (Rücklaufquote 52%). Im Mittel werden pro Klinik 46 Patienten mit Riechstörungen im Monat behandelt. Häufigste Ursachen sind Entzündungen der Nase/Nebenhöhlen (53%), gefolgt von respiratorischen (19%) und postviralen Riechstörungen (11%). Bei der pharmakologischen Therapie finden Steroide die breiteste Anwendung (topisch: 82%; systemisch: 65%), über 40% verwenden Vitamin-Komplexe und Zink. Chirurgische Maßnahmen werden von 80% zur Behandlung der Grunderkrankung eingesetzt (meist NNH-OPs; Septumplastiken).

Schlussfolgerungen

Basierend auf den hier erhobenen Daten werden pro Jahr mehr als 79.000 Patienten mit Riechstörungen (meist sinunasaler Ätiologie) alleine an deutschen HNO-Kliniken behandelt. Die Behandlungskonzepte bei Riechstörungen sind regional sehr unterschiedlich, ebenso die Indikationsstellung für eine Therapie unter Berücksichtigung der Ätiologie. Maßnahmen zur Qualitätssicherung der Therapie von Riechstörungen sind daher dringend erforderlich.

Schlüsselwörter

Anosmie Hyposmie Kortison Postviral Vitamine 

Abstract

Introduction

Olfactory dysfunction has been reported to affect more than 200,000 patients a year in the USA. The aim of this survey was to obtain comparable epidemiological data and treatment information on olfactory dysfunction in German speaking countries.

Methods

Questionnaires were sent to all otorhinolaryngology departments in Germany, Austria and Switzerland; 52% of hospitals completed the survey.

Results

An average of 46 patients with olfactory dysfunction were treated per hospital every month. Hyp- and anosmia were most commonly caused by inflammatory diseases of the nose/paranasal sinuses (53%), respiratory dysfunction (19%), or postviral conditions (11%). Steroids were used most frequently for pharmacological treatment (topically 82%; orally 65%). Approximately one third of the clinics used B vitamins, or zinc; 80% of the hospitals performed surgery to treat underlying diseases. Acupuncture and smell training was used by approximately 20%.

Conclusion

A total of 79,000 patients per year are treated for olfactory dysfunction in German hospitals. The vast majority of these disorders (72%) is caused by sinunasal diseases. The quality control of therapeutic strategies is urgently needed.

Keywords

Anosmia Hyposmia Nasal Steroids Surgery 

Notes

Danksagung

Die Autoren bedanken sich bei allen Teilnehmern der Umfrage für die interessierte Mitarbeit.

Literatur

  1. 1.
    Report of the Panel on Communication Disorders to the National Advisory Neurological and Communicative Disorders and Stroke Council (1979) Public Health Service (NIH Publication No. 79-1914), 319.1979. Washington/DCGoogle Scholar
  2. 2.
    Cassirer AM (1981) The missing zinc. J Am Med Womens Assoc 36:269–270Google Scholar
  3. 3.
    Damm M, Eckel HE, Jungehülsing M, Hummel T (2003) Olfactory changes at threshold and suprathreshold levels following septoplasty with partial inferior turbinectomy. Ann Otol Rhinol Laryngol 112:91–97CrossRefPubMedGoogle Scholar
  4. 4.
    Damm M, Eckel HE, Streppel M, Jungehülsing M, Stennert E (2000) Abhängigkeit des uni- und bilateralen Riechvermögens von der nasalen Strömung bei Patienten mit chronischer Rhinosinusitis. HNO 48:436–443CrossRefPubMedGoogle Scholar
  5. 5.
    Damm M, Jungehülsing M, Eckel HE, Schmidt M, Theissen P (1999) Effects of systemic steroid treatment in chronic polypoid rhinosinusitis evaluated with magnetic resonance imaging. Otolaryngol Head Neck Surg 120:517–523CrossRefPubMedGoogle Scholar
  6. 6.
    Damm M, Vent J, Schmidt M et al. (2002) Intranasal volume and olfactory function. Chem Senses 27:831–839CrossRefPubMedGoogle Scholar
  7. 7.
    Deems DA, Doty RL, Settle RG et al. (1991) Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center. Arch Otolaryngol Head Neck Surg 117:519–528CrossRefPubMedGoogle Scholar
  8. 8.
    Delank KW, Stoll W (1998) Olfactory function after functional endoscopic sinus surgery for chronic sinusitis. Rhinology 36:15–19PubMedGoogle Scholar
  9. 9.
    Doty RL, Shaman P, Dann M (1984) Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav 32:489–502CrossRefPubMedGoogle Scholar
  10. 10.
    Downey LL, Jacobs JB, Lebowitz RA (1996) Anosmia and chronic sinus disease. Otolaryngol Head Neck Surg 115:24–28CrossRefPubMedGoogle Scholar
  11. 11.
    Durr J, Lindemann J, Keck T (2002) Untersuchungen zur Riechfunktion vor und nach funktionellasthetischer Nasenoperation. HNO 50:626–629CrossRefPubMedGoogle Scholar
  12. 12.
    el Naggar M, Kale S, Aldren C, Martin F (1995) Effect of Beconase nasal spray on olfactory function in post-nasal polypectomy patients: a prospective controlled trial. J Laryngol Otol 109:941–944Google Scholar
  13. 13.
    Fein BT, Kamin PB, Fein NN (1966) The loss of sense of smell in nasal allergy. Ann Allergy 24:278–283PubMedGoogle Scholar
  14. 14.
    Fong KJ, Kern RC, Foster JD, Zhao JC, Pitovski DZ (1999) Olfactory secretion and sodium, potassium-adenosine triphosphatase: regulation by corticosteroids. Laryngoscope 109:383–388CrossRefPubMedGoogle Scholar
  15. 15.
    Garrett-Laster M, Russel RM, Jacques PF (1984) Impairment of taste and olfaction in patients with cirrhosis: the role of vitamin A. Hum Nutr Clin Ntr 38:203–214Google Scholar
  16. 16.
    Henkin RI (1981) Olfaction in human disease. In: Otolaryngology (ed by English GM), Lippincott, Philadelphia, pp 1–39Google Scholar
  17. 17.
    Henkin RI, Laster L (1967) Relationship between vitamin A metabolism and decreased olfactory detection sensitivity in patients with abetalipoproteinemia and other types of malabsorption. J Clin Invest 46:1069CrossRefGoogle Scholar
  18. 18.
    Henkin RI, Schecter PJ, Friedewald WT, Demets DL, Raff M (1976) A double blind study of the effects of zinc sulfate on taste and smell dysfunction. Am J Med Sci 272:285–299CrossRefPubMedGoogle Scholar
  19. 19.
    Hosemann W, Görtzen W, Wohlleben R, Wolf SR, Wigand ME (1993) Olfaction after endoscopic endonasal ethmoidectomy. Am J Rhinology 7:11–15CrossRefGoogle Scholar
  20. 20.
    Hotchkiss WT (1956) Influence of prednisone on nasal polyposis with anosmia. Arch Otolaryngol Head Neck Surg 64:478–479CrossRefGoogle Scholar
  21. 21.
    Hummel T (1999) Riech- und Schmeckstörungen.http://www.hno.org/patient.htm
  22. 22.
    Hummel T, Klimek L, Welge-Lussen A et al. (2000) Chemosensorisch evozierte Potenziale zur klinischen Diagnostik von Riechstörungen. HNO 48:481–485CrossRefPubMedGoogle Scholar
  23. 23.
    Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G (1997) 'Sniffin' sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 22:39–52CrossRefPubMedGoogle Scholar
  24. 24.
    Hüttenbrink KB (1997) Riech- und Schmeckstörunge—Bewährtes und neues zu Diagnostik und Therapie. Laryngorhinootologie 76:506–514CrossRefPubMedGoogle Scholar
  25. 25.
    Ikeda K, Sakurada T, Suzaki Y, Takasaka T (1995) Efficacy of systemic corticosteroid treatment for anosmia with nasal and paranasal sinus disease. Rhinology 33:162–165PubMedGoogle Scholar
  26. 26.
    Klimek L, Bachert C (2000) Aktuelle Aspekte der nasalen Glukokortikosteroidtherapie. HNO 48:544–555CrossRefPubMedGoogle Scholar
  27. 27.
    Klimek L, Hummel T, Moll B, Kobal G, Mann WJ (1998) Lateralized and bilateral olfactory function in patients with chronic sinusitis compared with healthy control subjects. Laryngoscope 108:111–114CrossRefPubMedGoogle Scholar
  28. 28.
    Klimek L, Moll B, Amedee RG, Mann WJ (1997) Olfactory function after microscopic endonasal surgery in patients with nasal polyps. Am J Rhinol 11:251–255CrossRefPubMedGoogle Scholar
  29. 29.
    Kobal G, Klimek L, Wolfensberger M et al. (2000) Multicenter investigation of 1,036 subjects using a standardized method for the assessment of olfactory function combining tests of odor identification, odor discrimination, and olfactory thresholds. Eur Arch Otorhinolaryngol 257:205–211CrossRefPubMedGoogle Scholar
  30. 30.
    Koch M, Koester M, Schanzer A, Constantinidis J, Iro H (2002) Metastasierendes Aesthesioneuroblastom. Herausforderung an ein interdisziplinäres multimodales Therapiekonzept. HNO 50:853–858CrossRefPubMedGoogle Scholar
  31. 31.
    Krueger KC, Krueger WB (1980) Hypogeusia and hyposmia associated with low serum zinc levels, a case report. J Am Med Womens Assoc 35:109–111Google Scholar
  32. 32.
    Lildholdt T, Rundcrantz H, Lindqvist N (1995) Efficacy of topical corticosteroid powder for nasal polyps: a double- blind, placebo-controlled study of budesonide. Clin Otolaryngol 20:26–30CrossRefPubMedGoogle Scholar
  33. 33.
    Lund VJ, Scadding GK (1994) Objective assessment of endoscopic sinus surgery in the management of chronic rhinosinusitis: an update. J Laryngol Otol 108:749–753CrossRefPubMedGoogle Scholar
  34. 34.
    Min YG, Yun YS, Song BH, Cho YS, Lee KS (1995) Recovery of nasal physiology after functional endoscopic sinus surgery: olfaction and mucociliary transport. ORL J Otorhinolaryngol Relat Spec 57:264–268CrossRefPubMedGoogle Scholar
  35. 35.
    Mott AE, Cain WS, Lafreniere D et al. (1997) Topical corticosteroid treatment of anosmia associated with nasal and sinus disease. Arch Otolaryngol Head Neck Surg 123:367–372CrossRefPubMedGoogle Scholar
  36. 36.
    Mott AE, Leopold DA (1991) Disorders in taste and smell. Med Clin North Am 75:1321–1353CrossRefPubMedGoogle Scholar
  37. 37.
    Mundt B, Krakowsky G, Roder H, Werner E (1987) Ger Psychiatr Neurol Med Psychol (Leipz) 39:356–361Google Scholar
  38. 38.
    Mygind N, Lildholdt T (1996) Nasal polyps treatment: medical management. Allergy Asthma Proc 17:275–282CrossRefPubMedGoogle Scholar
  39. 39.
    Nordin S, Murphy C, Davidson TM et al. (1996) Prevalence and assessment of qualitative olfactory dysfunction in different age groups. Laryngoscope 106:739–744CrossRefPubMedGoogle Scholar
  40. 40.
    Robinson AM, Kern RC, Foster JD, Fong KJ, Pitovski DZ (1998) Expression of glucocorticoid receptor mRNA and protein in the olfactory mucosa: physiologic and pathophysiologic implications. Laryngoscope 108:1238–1242CrossRefPubMedGoogle Scholar
  41. 41.
    Schecter PJ, Friedewald WT, Bonzert OA (1972) Idiopathic hypogeusia: A description of the syndrome and a single-blind study with zinc sulfate. Int Rev Neurobiol (Suppl 1): 125–140Google Scholar
  42. 42.
    Seiden AM, Duncan HJ (2001) The diagnosis of a conductive olfactory loss. Laryngoscope 111:9–14CrossRefPubMedGoogle Scholar
  43. 43.
    Statistisches Bundesamt (1999) Diagnosedaten der Krankenhauspatienten. (Fachserie 12 Reihe 6.2) Metzler Poechel, Stuttgart, S 12–13Google Scholar
  44. 44.
    Temmel AF, Quint C, Schickinger-Fischer B et al. (2002) Characteristics of olfactory disorders in relation to major causes of olfactory loss. Arch Otolaryngol Head Neck Surg 128:635–641CrossRefPubMedGoogle Scholar
  45. 45.
    Toft A, Wihl JA, Toxman J, Mygind N (1982) Double-blind comparison between beclomethasone dipropionate as aerosol and as powder in patients with nasal polyposis. Clin Allergy 12:391–401CrossRefPubMedGoogle Scholar
  46. 46.
    van Camp C, Clement PA (1994) Results of oral steroid treatment in nasal polyposis. Rhinology 32:5–9Google Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • M. Damm
    • 1
    • 6
  • A. Temmel
    • 2
  • A. Welge-Lüssen
    • 3
  • H. E. Eckel
    • 1
  • M.-P. Kreft
    • 1
  • J. P. Klussmann
    • 1
  • H. Gudziol
    • 4
  • K.-B. Hüttenbrink
    • 5
  • T. Hummel
    • 5
  1. 1.Hals-Nasen-Ohren-KlinikUniversität zu KölnKölnGermany
  2. 2.Hals-Nasen-Ohren-KlinikAKH WienWienGermany
  3. 3.Hals-Nasen-Ohren-KlinikUniversität BaselBasel
  4. 4.Hals-Nasen-Ohren-KlinikUniversität JenaJenaGermany
  5. 5.Hals-Nasen-Ohren-KlinikUniversität DresdenDresden
  6. 6.Hals-Nasen-Ohren-Klinik und PoliklinikUniversität zu KölnKölnGermany

Personalised recommendations